Skip to content

MEDESTHET

Active Private limited companyfounded 2024active for 2 yearsRobert Dalechamplaan 58, 1200 Woluwe-Saint-LambertKBO/BCE: BE 1006.554.548

Lifetime

2 annual accounts with figures on one time axis
peak €102,443 (2024)
€75,025▼ 26.8%
peak €66,735 (2024)
€45,276▼ 32.2%
peak €114,011 (2025)
€114,011▲ 65.9%
€55,929▼ 14.1%
Board1 name since 2024
1 director
Documentsfilings and deeds
22-06-202639 days before the deadline
2025micro format
Gross margin from €102,443 to €75,025Result from €66,735 to €45,276Registered office moved within Woluwe-Saint-Lambert 26-03Equity from €68,735 to €114,011

Key points

from the 2025 annual accounts

Turnover

≈ €170,000 estimated

The micro format states no turnover.

Liquidity

4.36 was 2.48 in 2024

Short-term debts rose from €26,941 to €28,099.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,326 companies had the same profile as MEDESTHET has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,326 companies, not a prediction for MEDESTHET. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 28-02-2024
  • 100 sharesdeed of 01-03-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1006554548
Registered office moved within Woluwe-Saint-Lambert New registered office: Avenue Robert Dalechamp 58, 1200 Woluwe-Saint-Lambert · Previous registered office: Avenue de Janvier 5, 1200 Woluwe-Saint-Lambert · General meeting of 01-12-2024 · Gazette deed
Incorporation Founding capital of €2,000, 100 shares · Founder: · Appointment: (director) · published on 01-03-2024 · Gazette deed
First establishment Robert Dalechamplaan 58, Woluwe-Saint-Lambert
All 7 events

Comparable companies

same main activity, similar in size and age
Company
MEDESTHET Woluwe-Saint-Lambert €169,941 €75,025 67.1% -
L’ENTRE ACTE MEDICAL Brussels €184,156 €78,698 86.4% -
A.S.K DOCTORS Schaerbeek €154,429 €78,954 79.1% -
Dokter Thomas Willems Lanaken €169,311 €78,305 87.3% -
Cabinet Médical FANARA Laura Chapelle-lez-Herlaimont €181,729 €76,991 78.0% -
Dr. Julie Lecomte Brecht €160,447 €77,703 80.9% -
Van Merhaeghe Lynn huisarts Maarkedal €177,256 €71,632 44.6% -

These companies have the same main activity as MEDESTHET: general medical practice (NACE 86210). They are comparable in size and age: total assets between €154,000 and €184,000, founded in 2023.

Official details

Source: KBO
Status
Active since 28-02-2024Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.356.279.3591200 Woluwe-Saint-Lambert, since 28-02-2024
Financial year end
31 December
Peppol
Reachable since 17-01-2026
Company details

Annual accounts 2025

€169,941▲ 27.0%
Filing
Filed on 22-06-2026, 39 days before the end of the filing period
Financials

Insights on MEDESTHET

MEDESTHET has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114,011 and a net result of €45,276.

Its solvency ranks better than 54% of 21,334 sector peers (NACE 86, financial year 2025).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDESTHET

What is the company number of MEDESTHET?
The company number of MEDESTHET is 1006.554.548. The VAT number is the same number with BE in front: BE 1006.554.548.
Where is MEDESTHET based?
The registered office is at Robert Dalechamplaan 58, 1200 Woluwe-Saint-Lambert.Company details
What does MEDESTHET do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of MEDESTHET?
MEDESTHET is a private limited company (BV).
When was MEDESTHET founded?
MEDESTHET was founded on 28-02-2024.
Is MEDESTHET still active?
Yes, MEDESTHET is an active enterprise in the KBO register.
What is the turnover of MEDESTHET?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €75,025 and 34 comparable companies (NACE 862). It probably lies between €130,000 and €210,000.Financials
Is MEDESTHET profitable?
In financial year 2025, MEDESTHET made a profit of €45,276.
Where can I find the annual accounts of MEDESTHET?
MEDESTHET filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDESTHET due?
MEDESTHET must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.